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GATA-1-dependent transcription is essential for
erythroid differentiation and maturation. Suppres-
sion of programmed cell death is also thought to be
critical for this process; however, the link between
these two features of erythropoiesis has remained
elusive. Here, we show that the POZ-Kru¨ppel family
transcription factor, LRF (also known as Zbtb7a/
Pokemon), is a direct target of GATA1 and plays an
essential antiapoptotic role during terminal erythroid
differentiation. We find that loss of Lrf leads to lethal
anemia in embryos, due to increased apoptosis
of late-stage erythroblasts. This programmed cell
death is Arf and p53 independent and is instead
mediated by upregulation of the proapoptotic factor
Bim. We identify Lrf as a direct repressor ofBim tran-
scription. In strong support of this mechanism,
genetic Bim loss delays the lethality of Lrf-deficient
embryos and rescues their anemia phenotype.
Thus, our data define a key transcriptional cascade
for effective erythropoiesis, whereby GATA-1 sup-
presses BIM-mediated apoptosis via LRF.
INTRODUCTION
Production of red blood cells (RBCs) is normally maintained at
a constant level by a finely tuned regulation of erythropoiesis.
During terminal maturation, mammalian erythroblasts extrude
their nuclei and give rise to RBCs. Over the past 20 years a wealth
of experimental evidence has unveiled the role of critical genes
during erythropoiesis (Godin and Cumano, 2002). In particular,
lineage-specific transcription factors and cytokines regulateDeveloerythroid cell fate by activating or inactivating key factors for
cellular differentiation and survival. The nuclear protein GATA1
is highly expressed in the erythroid lineages and activates the
transcription factor Eklf (Crossley et al., 1994; Welch et al.,
2004) along with many other erythroid-specific genes. Disruption
of the Gata1 gene in mice causes embryonic lethality due to
defects in yolk sac primitive erythropoiesis (Fujiwara et al.,
1996). Furthermore, hematopoietic differentiation of Gata1-null
embryonic stem (ES) cells in vitro revealed a block of differentia-
tion at the proerythroblast stage due to developmental arrest and
apoptosis (Weiss et al., 1994), indicating that Gata1 also plays
a key role in definitive erythropoiesis. How GATA1 regulates
differentiation and survival of immature erythroblasts is not fully
understood. The GATA1 target EKLF acts primarily as a tran-
scriptional activator and induces multiple erythroid-specific
genes (Hodge et al., 2006). Eklf-knockout mice die of severe
anemia by 16.5 days postcoitum (d.p.c.) due to defective defin-
itive erythropoiesis (Perkins et al., 1995). Erythropoietin (EPO)
and its receptor (EPO-R) are also essential for RBC production
and deliver key signals for erythroid cell survival (Richmond
et al., 2005). EPO activates multiple signaling pathways and
induces the antiapoptosis factor Bcl-XL (Richmond et al., 2005;
Socolovsky et al., 1999). Both Epo- and Epo-R-knockout mice
are embryonic lethal due to a lack of definitive erythropoiesis
(Wu et al., 1995).
LRF (encoded by the ZBTB7a gene, formerly described as
POKEMON [Davies et al., 1999; Maeda et al., 2005], FBI-1 [Pess-
ler et al., 1997], and OCZF [Kukita et al., 1999)]) is a transcription
factor that belongs to the POK (POZ/BTB and Kru¨ppel) protein
family. POK proteins bind DNA through C-terminal Kru¨ppel-
type zinc fingers and recruit corepressor complexes through
the N-terminal POZ/BTB domain (Stogios et al., 2005). POK
proteins act as transcriptional repressors and play important
roles in cellular differentiation and oncogenesis (Costoya et al.,
2004; He et al., 2005). We previously reported that Lrf can actpmental Cell 17, 527–540, October 20, 2009 ª2009 Elsevier Inc. 527
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Role of LRF in Terminal Erythroid Differentiationas a proto-oncogene through repression of Arf: specifically, Lrf
can trigger lymphomagenesis in the mouse and it is markedly
overexpressed in non-Hodgkin’s lymphoma cells (Maeda et al.,
2005). We have also shown that LRF critically regulates B versus
T lymphocyte fate decisions by opposing the Notch signaling
pathway. Conditional loss of Lrf in adult hematopoietic stem cells
(HSCs) results in the aberrant development of bone marrow
(BM) CD4/CD8 double-positive T cells, at the expense of B cell
development (Maeda et al., 2007). Here we show that
Lrf exerts an essential role for the biology of erythroid precursors.
We demonstrate that Lrf acts downstream of Gata1 by sup-
pressing Bim-mediated apoptosis, thus ensuring continued pro-
duction of RBCs.
RESULTS
Lrf Is Required for Definitive Fetal Erythropoiesis
Zbtb7a+/ mutants (Maeda et al., 2005) were seemingly healthy
and fertile, but intercrossing did not produce any live Zbtb7a/
progeny. When we analyzed embryos from timed pregnancies
of Zbtb7a+/ intercrosses, we found that until 12.5 d.p.c. the
null embryos were present at normal Mendelian ratio and most
of them had no gross morphological abnormalities (not shown).
However, by 14.5 d.p.c. the peripheral blood (PB) from
Zbtb7a/ embryos revealed large numbers of erythroblasts at
the polychromatophilic to orthochromic stage, as though their
further maturation was blocked: indeed, there were very few
mature red cells (Figure 1C, top). All Zbtb7a/ embryos died
between 15.5 and 16.5 d.p.c. This was likely due to anemia as
indicated by severe pallor and a marked reduction in the hemat-
ocrit (Figure 1A and 1B). Moreover, touch preparations of 14.5
d.p.c. fetal liver (FL) demonstrated a lack of enucleated erythro-
cytes and a preponderance of immature precursors (Figure 1C,
bottom). Because the 14.5 d.p.c. FL cell compartment consists
mainly of erythroblasts, we obtained from each genotype total
FL cell counts; these were significantly reduced in Zbtb7a/
embryos (Figure 1D). Furthermore, differential counts demon-
strated in Zbtb7a/ embryos a severe decrease in polychro-
matophilic and orthochromatophilic erythroblasts, as well as in
erythrocytes (Figure 1E). Stages of erythroid development can
be characterized by flow cytometric analysis (FACS) on the basis
of expression of Ter119 and CD71. As shown in Figure S1 (avail-
able online), the CD71+Ter119 population (R1) consists mainly
of proerythroblasts and early basophilic erythroblasts, whereas
the CD71+Ter119+ population (R2) is composed of basophilic
erythroblasts and early polychromatophilic erythroblasts. The
CD71Ter119+ population (R3) is a more heterogeneous popula-
tion and consists of poly/orthochromatophilic erythroblasts
and enucleated erythrocytes. FACS analysis revealed a severe
defect in terminal erythroid differentiation in Zbtb7a/ FLs (Fig-
ure 1F). Proportions of R2 and R3 were significantly decreased
in Zbtb7a/ FLs, whereas R1 was barely affected (Figure 1F).
This observation was more evident in later embryonic days
(14.5 d.p.c.), in which exponential expansion of mature erythro-
blasts occurs (Figure 1F). In addition, purified Zbtb7a/ erythro-
blasts from each stage, particularly the later ones, exhibited a less
condensed chromatin pattern compared with wild-type embryos
(Figure S1). Therefore, loss of Lrf causes lethal embryonic anemia
with impaired erythroid maturation. This severe anemia is not due528 Developmental Cell 17, 527–540, October 20, 2009 ª2009 Elseto lack of erythroid progenitors, as shown by colony assays from
13.5 d.p.c. FL (Figure 1G). However, whereas Zbtb7a+/+ colonies
were largely composed of mature erythrocytes, CFU-E colonies
from Zbtb7a/ mutants did not contain mature enucleated cells
(Figure 1G right). In order to verify the cell intrinsic nature of this
phenotype, we introduced an Lrf retroviral vector in Zbtb7a/
early erythroblasts, followed by differentiation in vitro. As shown
in Figure 1H, Lrf almost completely rescued the differentiation
defect in Zbtb7a/ cells. Lrf-infected erythroblasts (GFP posi-
tive), but not GFP negative cells, successfully differentiated into
Ter119-positive, small, mature erythroblasts in vitro.
Conditional Ablation of Lrf in the Adult Causes
an EPO-Unresponsive Macrocytic Anemia
To further elucidate the role of LRF in erythropoiesis, we next
produced Lrf conditional knockout mice (Maeda et al., 2007)
and made use of Mx1-Cre transgenic mice, in which Cre recom-
binase can be induced specifically in HSCs by the administration
of polyinosinic-polycytidylic acid (pIpC) (Kuhn et al., 1995).
In Zbtb7aFlox/FloxMx1cre+ mice, RBC and hematocrit gradually
decreased after pIpC administration, whereas their mean
corpuscular volume (MCV) increased, suggesting that erythro-
poiesis was abnormal not only quantitatively but also qualita-
tively (Figure 2A). One month after pIpC injection we found that
serum EPO levels in pIpC-treated Zbtb7aFlox/FloxMx1cre+ mice
were in fact high (Figure 2B), reflecting an appropriate physiolog-
ical response to the anemia caused by loss of Lrf. FACS analysis
in BM and spleen demonstrated that mature erythroblasts and
erythrocytes (R IV) (Socolovsky et al., 2001) were dramatically
decreased, while the early erythroblast compartment (R II) was
expanded in Lrf conditional knockout mice (Figure 2C); thus
these mice displayed an erythroid defect specifically at the
transition from R II to III/IV, which corresponds to basophilic
erythroblasts and poly/orthochromatic erythroblasts, respec-
tively, consistent with our findings in Lrf knockout embryos.
Splenomegaly in pIpC-treated Zbtb7aFlox/FloxMx1cre+ mice is
most likely due to a compensatory expansion of the early
erythroid compartment that is negative for Lrf (Figure 2D and
Figure S2A). In the BM of these mice, absolute numbers of
MEPs (megakaryo-erythrocytic progenitors) were increased
(Figure 2E) and they gave rise to comparable numbers of CFU-
E colonies as the controls (Figure 2F), suggesting that loss of
Lrf does not affect erythroid lineage commitment.
Anemia triggered by conditional inactivation of Lrf was even
more evident in a transplant model (Figure S2B). However, recip-
ients with BM reconstituted from Zbtb7aFlox/-Mx1cre+ cells devel-
oped severe macrocytic anemia upon pIpC administration
(Figure S2C). Taken together, these data support the notion
that the anemia in Lrf conditional knockout mice is caused by
a cell-intrinsic mechanism.
We next examined how Lrf conditional knockout mice would
respond to a severe hemolytic stress. Upon treatment with the
potent hemolytic agent phenylhydrazine (PHZ: see Socolovsky
et al., 2001), Lrf-ablated mice developed more severe anemia
than control mice; also, they had a delayed reticulocyte response
(Figure 2G) and a striking increase of PB mononuclear cells
(MNCs), which consisted almost exclusively of nucleated Lrf-
deficient erythroblasts (Figures 2H, S2D, and S2E). We conclude
that upon hemolytic stress, Lrf conditional knockout mice werevier Inc.
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Figure 1. Loss of Lrf Results in Embryonic Lethality due to Severe Anemia
(A) Picture of Zbtb7a+/+ and Zbtb7a/ 15.5 d.p.c. embryos.
(B) Hematocrit of Zbtb7a+/+, Zbtb7a+/, and Zbtb7a/ littermate embryos at 15.5 d.p.c.
(C) PB and FL touch preparation from Zbtb7a+/+ and Zbtb7a/ littermate embryos at 14.5 d.p.c.
(D) Total cell numbers per FL for each genotype at different embryonic days.
(E) Differential counts on FL cells from Zbtb7a+/+ and Zbtb7/ littermate embryos.
(F) Representative FACS profiles of 12.5 d.p.c. and 14.5 d.p.c. FLs from Zbtb7a+/+ and Zbtb7a/ embryos. Bar graph represents proportions of each population
in 12.5 d.p.c. FLs.
(G) Colony counts of in vitro differentiated FL precursors derived from 13.5 d.p.c. littermate embryos (left). Pictures demonstrate cytospin preparations of CFU-E
colonies from Zbtb7a+/+ (top) and Zbtb7a/ FLs (bottom).
(H) Lrf add-back into Zbtb7a/ erythroblasts rescued impaired differentiation phenotype in vitro. Both Zbtb7a+/+ and Zbtb7a/ immature erythroblasts
(Ter119Gr1B220) were isolated from 12.5 d.p.c. FLs and infected with either MSCV-Puro-IRES-GFP (PIG) empty vector or PIG-Lrf vector (Maeda et al.,
2005). We then induced erythroid differentiation in vitro and subsequently analyzed for Ter119 expression and cell size (forward scatter: FSC) by FACS. All error
bars indicate standard deviation (SD).Developmental Cell 17, 527–540, October 20, 2009 ª2009 Elsevier Inc. 529
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Role of LRF in Terminal Erythroid Differentiationable to mobilize immature nucleated erythroblasts from BM and
spleen into the peripheral blood, but they suffered even more
anemia than control mice.
Loss of Lrf Triggers Arf/p53-Independent Apoptosis
during Late Stages of Erythroid Development
To further elucidate the mechanism by which loss of Lrf causes
ineffective erythropoiesis, we first analyzed the cell cycle in
Zbtb7a/ FLs. As shown in Figure S2F, we found in FLs of these
mice a relative increase of cells in G1 and a concomitant
decrease of cells in S and G2/M. Next we looked for evidence
of apoptosis and found a dramatic increase of Annexin V-positive
apoptotic cells (Figure 3A); this was so pronounced, particularly
in the later stage of erythroid differentiation (R2), that we suggest
it could account for the lethal anemia of Zbtb7a/ embryos.
Because loss of the tumor suppressor Arf reverted the senes-
cence phenotype in Zbtb7a/ MEFs (mouse embryonic fibro-
blasts) (Maeda et al., 2005) and p19Arf mRNA was only detect-
able in Zbtb7a/ CD71+Ter119 erythroblasts by real-time
polymerase chain reaction (RT-PCR) (not shown), we next set
out to examine whether loss of Arf could bypass apoptosis
and rescue the anemia phenotype in Zbtb7a/ embryos. We
intercrossed Zbtb7a+/p19Arf+/ double-heterozygous mice
and analyzed FL erythropoiesis in 15.5 d.p.c. embryos. As
shown in Figure S3A, Zbtb7a/p19Arf/ embryos still demon-
strated a block of differentiation at the R2 stage and total
numbers of Zbtb7a/p19Arf/ FL cells were comparable to
Zbtb7a/p19Arf+/+ embryos (Figure S3B).
The tumor suppressor p53 inhibits cellular proliferation by
inducing cell cycle arrest and apoptosis in response to cellular
stresses such as DNA damage and hypoxia (Fridman and
Lowe, 2003). Furthermore, we found that p53 itself is upregu-
lated in Zbtb7a/ fetal liver erythroblasts (see below). We there-
fore tested whether genetic inactivation of p53 could rescue the
anemia phenotype of Zbtb7a/ mice. As shown in Figure S3C,
Zbtb7a/p53/ FLs still displayed a block of differentiation.
These data suggest that the massive apoptosis at late stages
of erythroid differentiation caused by loss of Lrf occurs in a
p19Arf/p53-independent fashion.
Intact EPO Signaling Cascade in Lrf-Deficient
Erythroblasts
EPO plays a key role in terminal erythroid differentiation by
preventing apoptosis in mature erythroblasts. To investigate
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Figure 2. Ablation of Lrf in the Hematopoi-
etic Compartment of Adult Mice Results in
Macrocytic Anemia and Ineffective Erythro-
poiesis
(A) We examined four different groups of
mice according to genotype and treatment:
Zbtb7aFlox/+Mx1cre+ PBS treated (blue),
Zbtb7aFlox/+Mx1cre+ pIpC treated (red),
Zbtb7aFlox/FloxMx1cre+ PBS treated (yellow), and
Zbtb7aFlox/FloxMx1cre+ pIpC-treated (green). RBC
counts, hematocrit, hemoglobin, and MCV in PB
were measured by a hematology analyzer. The
average of five animals was plotted at each time
point with error bars.
(B) Serum EPO level 1 month after pIpC injection.
(C) Representative FACS profiles for Ter119 and
CD71 expression in BM and spleen 1 month after
pIpC administration (left). Bar graphs represent
percent of each population in BM and spleen
(right).
(D) Representative hematoxylin and eosin staining
of spleen sections (top), demonstrating expansion
of red pulp formation in the spleen of pIpC-treated
Zbtb7aFlox/FloxMx1cre+ mice (middle panels for
Ter119 and bottom panels for Lrf staining).
(E) Absolute numbers of megakaryocyte/erythroid
progenitors (MEPs) in the BM 1 month after pIpC
administration. Black bars resent the average
cell counts of three mice.
(F) Erythroid colony-forming capacity per 10,000
flow-sorted MEPs was assessed in three indepen-
dent mice for each genotype.
(G) RBC counts, hematocrit, and MCV were
measured in the PB on indicated days after PHZ
treatment. Reticulocytes were counted on PB
smear slides upon new methylene blue staining.
(H) Robust increase of PB MNCs in PHZ-treated,
pIpC-pretreated Zbtb7aFlox/FloxMx1cre+ mice
(bottom). Pictures demonstrate Wright-Giemsa
staining of PB on day 3. All error bars indicate SD.530 Developmental Cell 17, 527–540, October 20, 2009 ª2009 Elsevier Inc.
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Role of LRF in Terminal Erythroid Differentiationwhether the loss of Lrf impairs EPO signaling, we examined acti-
vation status of signaling molecules upon EPO stimulation, such
as STAT5, ERK/MAPK, PI3K/AKT, and Bcl-XL (Richmond et al.,
2005; Socolovsky et al., 1999). Mice were treated with PHZ
and CD71+ splenic erythroblasts were harvested using magnetic
beads. Cells were serum starved for 2 hr and then stimulated
with EPO. We next assessed the phosphorylation status of
Stat5 by Western blot and FACS. As shown in Figures S4A
and S4B, activation of Stat5, ERK/MAPK and PI3K/AKT
was induced normally upon EPO stimulation in pIpC-treated
Zbtb7aflox/-Mx1Cre+ erythroblasts, indicating that upstream EPO
signaling is intact in the absence of Lrf. Furthermore, Bcl-XL
was abundantly expressed in pIpC-treated Zbtb7aflox/-Mx1Cre+
erythroblasts (Figure S4C). Of note, the antiapoptotic protein
Mcl1 was comparably expressed as well, whereas Bcl-2 protein
was slightly reduced in Zbtb7aflox/-Mx1Cre+ erythroblasts. Thus,
erythroid apoptosis observed in Lrf conditional knockout mice
is not due to an impaired EPO/EPO-R signaling pathway.
Upregulation of the Proapoptotic Factor Bim
in the Absence of Lrf
In order to understand how loss of Lrf results in erythroblast
apoptosis, we studied mRNA expression profiles in the R1
population of flow-sorted CD71+Ter119 FL erythroblasts
(Figure S5A). This population was selected for analysis because
it consists of cells at a differentiation stage that did not exhibit
overt cellular degeneration. A total of 189 probe sets were up
or downregulated more than 1.5-fold in Zbtb7a/ R1 cells as
compared with Zbtb7a+/+ and Zbtb7a+/ cells. From the list of
genes thus compiled (see Figure S6), we selected genes that
have been implicated in cellular apoptosis, differentiation, prolif-
eration, and the cell cycle (Figure S5A). Many genes known to be
involved in definitive erythropoiesis (Godin and Cumano, 2002)
were expressed normally in Zbtb7a/ R1 cells (Figure S5B).
Interestingly, the BH3 only protein Bim (O’Connor et al., 1998)
(encoded by Bcl2l11 gene), a major apoptosis inducer in hema-
topoietic cells (Strasser et al., 1995), was found to be markedly
upregulated with two independent probe sets in Zbtb7a/ R1
cells (Figure S5A). Because apoptosis of Zbtb7a/ FL erythro-
blasts was not reverted by Arf/p53 loss and Bim is known to
function in an Arf/p53-independent apoptosis pathway (Egle
et al., 2004; Hemann et al., 2005), we investigated further the
role of Bim in the defective erythropoiesis observed in the
absence of Lrf. We found high Bim mRNA expression and an
approximately 3-fold upregulation of Bim protein in flow-sorted
c-Kit+CD71+Ter119 Zbtb7a/ erythroblasts (Figure 3B and
Figure 3C). Furthermore, Bim-EL protein levels were significantly
elevated in CD71+ pIpC-treated Zbtb7aflox/-Mx1Cre+ splenic
erythroblasts irrespective of EPO signals, whereas Bcl-XL
protein level was similar to that of control cells (Figure 3D).
Markedly elevated Bim expression was also observed by immu-
nohistochemistry in both Zbtb7a/ 14.5 FL and pIpC-treated
Zbtb7aFlox/FloxMx1cre+ spleens (Figure 3E), indicating that Bim
upregulation is a characteristic feature of Lrf loss both in the
embryo and in the adult.
Bim Is a Direct Transcriptional Target of Lrf
Upregulation of Bim mRNA in Lrf deficient erythroblasts was due
to an increase in transcription of the Bim gene rather thanDevelopenhanced Bim mRNA stability, as reduction of Lrf expression
via siRNA-mediated knockdown in erythroblasts did not
affect Bim mRNA stability during erythroid differentiation
(Figure S7A). In multiple cell types, Bim is regulated by the tran-
scription factor Foxo3a downstream the PI3K/Akt pathway
(Dijkers et al., 2000; Stahl et al., 2002). We therefore examined
whether Bim upregulation in Zbtb7a/ erythroblasts might be
accompanied by an accumulation of Foxa3a protein in the
nucleus. As shown in Figures S7B and S7C, no significant
increase of nuclear Foxo3a protein was observed by immunohis-
tochemistry (IHC) in either Zbtb7a/ 15.5 FL or pIpC-treated
Zbtb7aflox/-Mx1Cre+ spleens, indicating that Bim upregulation in
Zbtb7a/ erythroblasts does not depend on Foxo3a.
Because LRF can act as a transcriptional repressor (Maeda
et al., 2005), we next tested whether Lrf directly represses Bim
transcription. To this end, we generated a set of luciferase
reporter constructs containing regions of the proximal Bim
promoter, and we assessed the ability of Lrf to repress reporter
activity. As shown in Figure 3F, Lrf efficiently repressed activity of
an 800 bp region of the Bim proximal promoter. Furthermore, by
generating a series of deletions and truncations of this 800 bp
fragment, we were able to identify a 250 bp region upstream of
the Bim transcription start site that had promoter activity and
was still sensitive to Lrf-mediated repression (Figure 3F). Within
this 250 bp proximal promoter region we identified four potential
LRF binding sites (Maeda et al., 2005) (Figure 3G). Although
mutation of any single LRF binding site alone did not impair
Lrf-mediated repression (data not shown), mutation of two adja-
cent sites close to the transcription start site abrogated Lrf-medi-
ated repression (Figure 3G). Further, Lrf was found to directly
bind to oligonucleotides that contain these putative LRF binding
sites in the Bim gene as demonstrated by electrophoretic
mobility shift assays. In addition, Lrf antibodies were found to
super-shift the Lrf-oligonucleotide complex (Figures S8D and
S8E). These data support a model whereby Lrf directly represses
Bim expression through a tandem-binding site in the Bim prox-
imal promoter region.
Chromatin immunoprecipitation (ChIP) experiments further
demonstrated a direct binding of LRF on the Bim promoter. We-
designed two primer sets; one to amplify the proximal humanBIM
promoter and another to amplify the 50 promoter of HPRT1 as
a negative control. LRF antibody specifically precipitated the
proximal BIM promoter sequences from chromatin preparations
of K562 erythroleukemia cells (Figure 3H). An important confirma-
tion of this result was obtained by inducing differentiation of
K562 cells with hemin (Figure 3H). (Rutherford et al., 1979). Under
these conditions LRF is upregulated, and an enhanced enrich-
ment of LRF at the BIM promoter was detected (Figure 3H).
We conclude that LRF directly binds to the BIM promoter and
inhibits its expression during erythroid differentiation.
Bim Deficiency Rescues the Anemia Observed
in Lrf-Knockout Mice
In order to define more clearly the functional role of the Lrf-Bim
interaction in suppressing apoptosis in erythroblasts, mice
heterozygous for both Lrf and Bim genes (Zbtb7a+/Bim+/)
were intercrossed to obtain Lrf/Bim double knockout embryos
(Zbtb7a/Bim/). As shown in Figure 4A, while Zbtb7a/
Bim+/+ 15.5 d.p.c. embryos were overtly pale, Zbtb7a/Bim/mental Cell 17, 527–540, October 20, 2009 ª2009 Elsevier Inc. 531
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Role of LRF in Terminal Erythroid Differentiationembryos appeared grossly normal. Bim deficiency significantly
increased total numbers of FL (Figure 4B) and mature erythroblast
(R3) cells in 12.5 d.p.c. and 14.5 d.p.c. embryos (Figures 4C, 4D,
and S8A). In the double-knockout mice, Annexin V-positive
apoptotic cells were nearly absent (Figures 4E, 4F, S8B, and
S8C), providing proof that removal ofBim is sufficient to abrogate
erythroblast apoptosis. Of note, Zbtb7a/ embryos heterozy-
gous forBim (Zbtb7a/Bim+/) displayed an intermediate pheno-
type (Figures 4B–4F). Thus, the rescue from fetal anemia of Lrf
knockout mice through loss of Bim is gene-dosage dependent.
These data prompted us to analyze the effect of Bim loss on
lethality seen in Zbtb7a/ embryos. To this end, Zbtb7a+/
Bim+/ mice were intercrossed, and their progenies were
analyzed at different embryonic days. Zbtb7a/ embryos were
alive at 14.5 d.p.c. irrespective of Bim genotype, but none of
the Zbtb7a/Bim+/+ or Zbtb7a/Bim+/ progenies were deliv-
ered (Table S1). However, 3 Zbtb7a/Bim/ pups out of 35
offspring analyzed were identified on the day of birth (P0), indi-
cating that complete loss of the Bim gene prolonged the survival
of Zbtb7a/ embryos (Table S1). These three Zbtb7a/Bim/
mice were nevertheless paler than controls at birth and subse-
quently died postnatally.
Overall, Bim loss was sufficient to restore nearly normal eryth-
ropoiesis in Zbtb7a/ FL up to 14.5 d.p.c. and partially rescued
lethality in Zbtb7a/ embryos. Our genetic analysis thus indi-
cates that excessive Bim expression is a primary cause of defec-
tive erythropoiesis in Zbtb7a/ FLs.
Lrf Is a Direct Transcriptional Target of Gata1
The Gata1 transcription factor plays a central role in erythroid
gene expression (Cantor and Orkin, 2002; Fujiwara et al., 1996)
and protects erythroblasts from apoptosis (Weiss and Orkin,
1995; Gregory et al., 1999). We next examined Gata1 expression
in pIpC-treated Zbtb7aflox/-Mx1Cre+ CD71+ erythroblasts. As
shown in Figure 5A, Gata1 protein is abundantly expressed in
pIpC-treated Zbtb7aflox/-Mx1Cre+ CD71+ erythroblasts.
LRF was recently identified as an EKLF-induced gene both in
fetal liver cells and erythroid cell lines (Hodge et al., 2006).DevelopBecause GATA1 is a transcriptional activator of EKLF (Crossley
et al., 1994), and EKLF is indispensable for fetal erythropoiesis
(Hodge et al., 2006; Perkins et al., 1995), we speculated that
LRF is a key downstream target of the GATA1/EKLF transcrip-
tional cascade enabling survival of differentiating erythroblasts.
Indeed, while examining the promoter regions of the mouse
Zbtb7agene, we found two putative GATA binding sites and three
EKLF consensus sequences (Figure 5B). Of note, the two putative
GATA binding sites are fully conserved in the promoter region of
the human ZBTB7A gene (not shown). To test whether Gata1 can
activate Lrf expression, we used the Gata1 null erythroid cell line
G1E (Gregory et al., 1999). These cells proliferate as immature
erythroblasts and undergo terminal maturation when Gata1
activity is restored. Upon activation of a drug-inducible form of
Gata1, Lrf mRNA was upregulated approximately 4-fold
(Figure 5C). We also observed upregulation of Eklf and Bcl-XL
and downregulation of Myb, as previously reported (Figure 5C)
(Gregory et al., 1999; Welch et al., 2004).
We next examined whether Gata1 upregulates Lrf transcrip-
tion via two putative GATA binding sites within the Lrf promoter.
Dual-luciferase reporter assay experiments demonstrated that
two Gata elements in the Zbtb7a gene act cooperatively to
enhance promoter activity in murine erythroleukemia (MEL) cells
(Figure 5D). To further elucidate the mechanism by which Gata1
induces Lrf, we performed ChIP experiments. Although we could
not detect Eklf binding to the Zbtb7a promoter (Figures S9A and
S9B), anti-Gata1 antibody specifically precipitated the 400 bp
proximal Zbtb7a promoter sequences, which contain the puta-
tive Gata1 binding sites, from extracts prepared from the
induced G1E2-ER4 cells, but not from the parental cell line
G1E2 (Rylski et al., 2003) (Figure 5E). As a further control, we
could also efficiently enrich the Fog1 promoter sequence
using anti-Gata1 antibody (Welch et al., 2004) (Figure S9C).
We obtained similar results in ChIP assays using MEL cells,
an independent experimental system for in vitro erythroid differ-
entiation (Figure 5F). These data indicate that Gata1 directly
binds to the Zbtb7a proximal promoter in vivo and activates Lrf
expression.Figure 3. Loss of Lrf Leads to Increased Apoptosis Accompanied by High Bim Expression
(A) Representative FACS profiles of the triple staining for Ter119, CD71, and Annexin V (left). Bar graph demonstrates the average of percentage Annexin V posi-
tivity in R1 and R2 cell populations.
(B) Bim mRNA was increased in Zbtb7a/ FL erythroblasts. c-Kit+CD71+Ter119 erythroblasts were flow sorted and RNA was extracted. cDNA was subse-
quently synthesized after DNase treatment and levels of Bim and Hprt1 transcripts were measured by quantitative RT-PCR. Bar graph represents normalized
expression level of Bim mRNA with error bars.
(C) Bim protein was upregulated in Zbtb7a/ FL erythroblasts. Different numbers of c-Kit+CD71+Ter119 erythroblasts (5,000, 10,000, and 20,000) were directly
flow-sorted into protein sample buffer and western blot was subsequently performed using anti-Bim antibody (left). Bar graph represents normalized Bim protein
level to the corresponding b-actin protein levels in c-Kit+CD71+Ter119 erythroblasts from 12.5 d.p.c. FLs (right).
(D) High Bim protein expression in pIpC-treated Zbtb7aFlox/-Mx1cre+ CD71+ splenic erythroblasts. CD71+splenic erythroblasts were harvested from PHZ-treated,
pIpC-pretreated Zbtb7aFlox/+Mx1cre and Zbtb7aFlox/-Mx1cre+ mice. Erythroblasts were then serum starved and subsequently stimulated with EPO. Cells were har-
vested 10 min after EPO administration and subsequently utilized for experiments.
(E) IHC analysis for Bim in FL and spleen. FLs were isolated from littermate embryos at 14.5 d.p.c. Spleens were collected 1 month after pIpC treatment. Both low-
power magnification (3100) and high-power magnification (insets, 3400) are shown.
(F) Transrepression assays in 293 cells transfected with various luciferase reporter constructs of the murine proximal Bim promoter.
(G) Identification of an essential LRF-binding site in the murine Bim promoter. The putative LRF-binding sites in the Bim promoter were mutagenized and subse-
quently used for reporter assays. Schematic representations of mutated promoter and expression control for the reporter assay are shown (bottom). Underlined
bases of the LRF-binding sites were mutated to adenine. Luciferase reporter plasmids were transfected into 293 cells. Luciferase activity was measured 24 hr
after transfection using the Dual-Luciferase Reporter Assay system. Lrf did not repress the promoter activity of mut3+4 reporter.
(H) Quantitative ChIP assay of the BIM promoter both in K562 cells and in induced K562 cells by hemin. Primer sets were designated to amplify the proximal
human BIM promoter and primers designated to the 50 promoter of HPRT1 were used to detect nonspecific interactions. The chromatin was sonicated to
200–600 bp. A western blot demonstrates that LRF is upregulated in induced K562 cells by hemin. All error bars indicate SD.mental Cell 17, 527–540, October 20, 2009 ª2009 Elsevier Inc. 533
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Role of LRF in Terminal Erythroid DifferentiationWe next asked whether Lrf overexpression restores terminal
erythroid differentiation in the absence of Gata1 using G1E-ER4
cells. We performed all experiments in the presence of EPO,
because G1E-ER4 cells underwent apoptosis in the absence of
EPO irrespective of Lrf levels (not shown). Retroviral overexpres-
sion of Lrf in G1E-ER4 cells led to an increase in Ter119-positive
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Figure 4. Loss of Bim Restores Erythropoiesis in Zbtb7a/ FL
(A) Picture of Zbtb7a Bim+/+, Zbtb7a/Bim+/, and Zbtb7a/Bim/ 15.5 d.p.c. embryos.
(B) Total cell numbers per FL for each genotype at different embryonic days. Three litters were isolated for each time point and average numbers are presented
with SD.
(C) Representative FACS profiles of 14.5 d.p.c. FLs from Zbtb7a/Bim+/+, Zbtb7a/Bim+/, and Zbtb7a/Bim/ 14.5 d.p.c. embryos.
(D) Bar graph shows R3 population in 14.5 d.p.c. FLs. Three embryos were obtained and analyzed for each genotype.
(E) Representative FACS profiles of the staining for Annexin V in R2 cell population.
(F) Bar graph demonstrates the average of percentage Annexin V positivity in R1 and R2 cell populations. Three FLs were analyzed for each genotype. All error
bars indicate SD.
534 Developmental Cell 17, 527–540, October 20, 2009 ª2009 Elsevier Inc.
Developmental Cell
Role of LRF in Terminal Erythroid DifferentiationGata1 Occupancy in MEL cells 
1
0
2
3
4
5
6
7
Lrf/Zbtb7a
Fog1
Positive Ctrl Negative Ctrl
GATA1 (0h)
GATA1 (48h)
rat IgG (48h)
rat IgG (0h)
R
el
at
iv
e 
O
cc
up
an
cy
CRM1 UpstreamUpstream Promoter
G1E-2
G1E-ER4 (-)
G1E-ER4 (+)
R
el
at
iv
e 
O
cc
up
an
cy
500bp
-2.1kb -400bp
Lrf/Zbtb7a
3.0
2.5
2.0
1.5
1.0
0.5
0
Gata1 Occupancy in G1E-ER4 cells
E
C
N
or
m
al
iz
ed
 m
R
N
A 
ex
pr
es
si
on
3
4
5
0
2
1
3
4
5
0
2
1
0h 12h 24h 48h
0h 12h 24h 48h
N
or
m
al
iz
ed
 m
R
N
A 
ex
pr
es
si
on
Lrf
Bcl-XL
Time after treatment
G1E-2 estradiol 
G1E-ER4 estradiol 
G1E-ER4 ethanol
3
4
5
0
2
1
0h 12h 24h 48h
Eklf
3
4
5
0
2
1
0h 12h 24h 48h
Myb
F
A
α-Hsp90
α-Gata1
+
e
r
C
 
+
/
F
2
#
+
e
r
C
 
-
/
F
1
#
+
e
r
C
 
-
/
F
+
/
+
B
AGGCCGGGGCTGTTTATCTGCGGCCCCCACCCCCTGAACCCGAGGGGCCC
CTCTTGCCCGCCCCCAGCACCCTGGGGTGCTCCGGGCCGTAGATAA GCCA
GCAGGCTGGCACGGCGCCGCGCACGGGGCGGAGAGGTCACGGGCTTGCCA
GGGGAGGGGCCGATGGGTCGGGGCTGCGCCCCCCGCCCGCCCGGCACCCC
CAAATCCCTAATC GCAGCCCGATCTGCTCTCGCGGCGCAGCCCCGCGGGA
D
AGATAA
-50
mLrf-luc WT
mutAB
mutB
 mutA
TTATCT
-100
TTAAAT
TTAAAT
TTATCT
AGATAA
ATTTAA
ATTTAA
GATA site A GATA site B
pGL4 empty SV40-luc WT
-1600
mutA mutB mutAB
ytivitca esar efi cuL evit al e
R
16
12
8
4
0
Figure 5. Lrf is a Gata1 Downstream Target
(A) Western blot for Gata1 in Zbtb7a+/+, Zbtb7aFlox/+Mx1cre, and Zbtb7aFlox/-Mx1cre+ CD71+ splenic erythroblasts. Gata1 was abundantly expressed in the absence
of Lrf.
(B) Sequence of 450 bases of the predicted promoter region of the Zbtb7a gene. Consensus EKLF CACCC boxes are underlined; consensus GATA1 binding
motifs are depicted in red and underlined; exon 1 sequence is shown in blue.
(C) G1E-ER4 is aGata1-ablated erythroblast line expressing an estradiol-inducible form of GATA1. G1E-ER4 cells and its parental cell line G1E-2 were stimulated
with 107 M estradiol or ethanol vehicle and RNA was extracted at the indicated times after stimulation. mRNA levels of Lrf, Eklf, Bcl-XL, and Myb were measured
by quantitative RT-PCR and normalized to the corresponding Hprt1 mRNA levels.
(D) Two GATA elements in the Zbtb7a gene act cooperatively to enhance promoter activity in erythroid cells.
(E) Quantitative ChIP assay at the Lrf promoter inGata1 null parental (G1E-2), uninduced (), and induced (+) G1E-ER4 cells using anti-Gata1 antibody. The y axis
shows Gata1 occupancy, relative to a standard curve of the relevant input sample. Below, diagram of the 50 end of theZbtb7agene. Thin black line indicates intron 1;
black box represents exon 1; checkered box represents the predicted promoter region, which contains 2 consensus GATA1 binding sites and 3 consensus EKLF
CACCC boxes; thin gray line represents the upstream intergenic region. Dashed boxes show regions amplified by quantitative RT-PCR for ChIP. Arrow indicates
direction of transcription.
(F) Quantitative ChIP assay using anti-GATA1 antibody in MEL cells chemically induced to differentiate for either 0 hr or 48 hr. Data from immunoprecipitations
performed with normal rat immunoglobin G are shown as controls. All error bars indicate SD.
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Role of LRF in Terminal Erythroid Differentiationerythrocytes (Figure 6A), accompanied by a reduction in Bim
mRNA levels (Figure S10A). Lrf-overexpressing G1E-ER4 cells
formed hemoglobinized erythroid colonies without Gata1 induc-
tion when seeded in methylcellulose plates (Figure S10B).
Conversely, siRNA-mediated Lrf knockdown resulted in
increase of apoptosis revealed by morphological examination
(Figure S10C) and Annexin V staining (Figure S10D). Successful
Lrf knockdown in siRNA-treated cells was confirmed by western
blot (Figure S10E). Furthermore, as expected, we observed
a significant increase of apoptotic erythroblasts when Bim was
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Figure 6. Lrf Overexpression Restores Erythroid Differentiation in Gata1-Deficient Erythroblasts
(A) Proportions of Ter119-positive G1E-ER4 cells upon Lrf overexpression without estradiol treatment (left). Representative FACS profiles for Ter119 expression is
also demonstrated with isotype control (left). Pictures demonstrate cytospin preparations of G1E-ER4 cells expressing empty vector or Lrf (right).
(B) Gata1 wild-type and null ES cells expressing either empty vector or Lrf were induced toward erythroid differentiation on OP9 stromal layers. Floating hema-
topoietic cells were harvested and analyzed. Representative FACS profiles of the staining for Annexin V in Ter119-positive cell population (left). Bar graph demon-
strates the average of percentage Annexin V positivity in Ter119-positive cell fraction (right).
(C) Sequential analysis for the numbers of floating blood cells derived from Gata1 null ES cells expressing either empty vector (yellow) or Lrf (green).
(D) May-Giemsa staining of floating erythrocytes (3400 magnification).
(E) Proposed model of the role for LRF in terminal erythroid differentiation. We propose that inhibition of apoptosis during erythroid terminal differentiation is
dependent on both the EPO/BCL-XL and the LRF/BIM pathways, which are activated in response to the transcription factor GATA1. Loss of the tumor suppressor
Arf reverted the senescence phenotype in Zbtb7a/ MEFs (Maeda et al., 2005). All error bars indicate SD.
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Role of LRF in Terminal Erythroid Differentiationectopically expressed in differentiating G1E-ER4 cells (Figures
S10F and S10G). Of note, the proapoptotic effects of Lrf knock
down as well as Bim overexpression became evident once
differentiation was initiated by Gata1 induction. This suggests
that Bim repression by Lrf is chiefly required in late stages of
erythroid differentiation, which is in complete agreement with
our findings in Lrf knockout mice.
To confirm our findings in primary cells, we next took advan-
tage of an OP9/mouse embryonic stem cell (ESC) coculture
system. We overexpressed Lrf in Gata1 null ES cells and exam-
ined erythroid differentiation (Weiss et al., 1994). In this system,
ES cells give rise to a nonadherent hematopoietic cell population
that includes erythrocytes (Umeda et al., 2004; Umeda et al.,
2006). Nonadherent cells were harvested serially and Annexin
V positivity within the Ter119-positive fraction was analyzed.
Lrf overexpression significantly augmented their survival (Fig-
ure 6B) and increased the production of nonadherent cells,
which consisted mainly of Ter119 erythroblasts (Figures 6C,
6D, and S10H). Thus, overexpression of Lrf partially overrides
erythroblast apoptosis and maturation arrest caused by lack of
Gata1.
DISCUSSION
The transcription factor LRF has previously been identified as
a regulator of the important tumor suppressor ARF, and cells
lacking Lrf have proved refractory to malignant transformation
(Maeda et al., 2005). LRF also plays an essential role in the
B versus T lymphoid cell-fate decision (Maeda et al., 2007):
thus, the gene encoding Lrf, Zbtb7a, belongs to the select group
of genes that have a crucial role in both oncogenesis and
development. In this work we have shown that the latter role
includes a function that is essential for erythropoiesis, and we
defined the mechanism whereby this function is fulfilled.
First, we have established that LRF plays a key role in fetal and
adult erythropoiesis. Zbtb7a/ embryos die of severe anemia
by 16.5 d.p.c.; and in adult mice conditional inactivation of Lrf
in HSCs results in an EPO-unresponsive macrocytic anemia
due to a cell intrinsic defect. Through targeted inactivation,
a number of other genes have been previously identified as
key factors in definitive erythropoiesis (Godin and Cumano,
2002). Upon EPO-R activation, STAT5 is phosphorylated, trans-
locates to the nucleus, and induces transcriptional activation of
target genes. Inactivation of both isoforms of Stat5 in mice
(Stat5a/Stat5b/) results in inefficient erythropoiesis in both
the fetus and the adult organism (Socolovsky et al., 2001). We
find similar phenotypic features in Lrf conditional knockout
mice, despite the fact that Lrf null erythroblasts have an intact
EPO-STAT5 signaling pathway. Indeed, Bcl-XL, a downstream
target of Stat5, is normally induced upon EPO stimulation in
the absence of Lrf (Figure S4C); and the MAPK and PI3K
pathways, which are also downstream of the EPO receptor,
are activated normally in Lrf null erythroblasts (Figure S4B).
Thus, the role of LRF in terminal erythroid differentiation does
not appear to be related to the EPO signaling cascade.
We have shown previously that LRF blocks the Notch pathway
in HSC/progenitor cells to regulate B versus T lineage fate
decision (Maeda et al., 2007). However, the defect in erythroid
differentiation in Lrf knockout mice was not rescued by inhibitionDevelopof Notch activity by treatment in vivo with a gamma secretase
inhibitor (Figure S11). Furthermore, a Notch activation signature
is not present in Lrf knockout MEP in contrast to our findings in
HSC/CLPs (common lymphoid progenitors) (Maeda et al.,
2007). Thus, failure of erythropoiesis upon loss of Lrf cannot be
accounted for by aberrant Notch activation.
Our next key finding was that Lrf loss causes apoptosis of
erythroblasts, mostly at the transition from the basophilic to
the polychromatophilic stage. The ARF/p53 pathway is critical
in the induction of apoptosis, cell cycle arrest, and cellular senes-
cence in response to oncogenic stress (Lowe and Sherr, 2003).
High p53 expression induces apoptosis in fetal liver erythro-
blasts and erythroid-specific inactivation of the mouse Mdm2
gene, a key negative regulator of p53, leads to increased
apoptosis in erythroblasts and embryonic lethality due to a
severe anemia (Mdm2lox/loxEpoRcre+) (Maetens et al., 2007).
However, neither Arf loss nor p53 loss could rescue the defects
in Lrf null erythroblasts (Figure S3 A–C): in other words,
apoptosis of Lrf null erythroblasts was Arf/p53 independent.
The mechanism whereby Lrf loss produces apoptosis was
clarified by analyzing the gene expression profile of Lrf null cells
by microarray. We focused on the fact that in Lrf null cells the
proapoptotic factor Bim was markedly upregulated at the level
of both mRNA and protein (Figures 3B–3E). Reporter assays
and ChIP experiments demonstrated that LRF physically binds
to the BIM promoter and directly represses transcription of this
gene (Figures 3F–3H). Probably the most convincing evidence
that Lrf function is linked to Bim comes from our genetic analysis:
if Bim is knocked out, the severe erythroid cell phenotype
of Zbtb7a/ mutants, including lethal anemia, is almost
completely reversed (Figures 4 and S8). The rescue is gene-
dosage dependent, because loss of even oneBim allele provides
a significant survival advantage to Zbtb7a/ erythroblasts
(Figures 4 and S8). Our data indicate that ‘‘fine-tuning’’ of Bim
levels via Lrf is key for erythroblast survival. BIM was already
known to function in an ARF/p53-independent apoptosis
pathway (Egle et al., 2004; Hemann et al., 2005). An important
implication of our work is that both p53- and Bim-dependent
apoptotic pathways must be suppressed for effective erythroid
differentiation.
Finally, we have discovered that LRF is a novel direct tran-
scriptional target of GATA1. Lrf mRNA expression was induced
upon Gata1 re-expression in a Gata1 null erythroblast cell line
(Figure 5C), and by ChIP analysis Gata1 is found to directly
bind to the Lrf promoter in vivo (Figures 5E and 5F). Gata1
expression is barely detectable at HSC/progenitor stages and
is upregulated during erythroid lineage commitment, being ex-
pressed at the highest levels in CFU-E and in proerythroblasts
(Suzuki et al., 2003). Gata1 null embryonic stem cells fail to
produce mature erythroid cells in vivo in chimeric mice (Pevny
et al., 1991) due to massive apoptosis of erythroblasts (Weiss
et al., 1994), demonstrating Gata1’s essential role as a survival
factor during this differentiation process. In this context, our
study identifies LRF as a key downstream target of GATA1. In
agreement with this notion, forced Lrf overexpression in Gata1
null cells led to Bim downregulation and prolonged the survival
of Gata1 null erythroblasts (Figures 6 and S10H), enabling
erythroid cells to undergo terminal maturation at least to some
extent.mental Cell 17, 527–540, October 20, 2009 ª2009 Elsevier Inc. 537
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Role of LRF in Terminal Erythroid DifferentiationThe differentiation and maturation of erythroid cells is a highly
regulated process: in its terminal stages, it exhibits features of
apoptosis (Weiss and Orkin, 1995; Gregory et al., 1999; Socolov-
sky et al., 1999; Yoshida et al., 2005). If apoptosis is abnormally
triggered at earlier stages of differentiation, the output of mature
erythrocytes will be compromised: this underlies the phenom-
enon of intramedullary destruction of red cell precursors known
as ineffective erythropoiesis, which causes anemia in inherited
disorders such as thalassemia (Rivella, 2009; Wu et al., 2005).
Here we have shown that control of the proapoptotic protein
BIM is critical for normal erythropoiesis: and this control is ex-
erted by LRF. If we consider hematopoiesis as a whole, we
can speculate that although BIM is essential in lymphoid cells
for preventing autoimmunity (Bouillet et al., 1999), it is essential
that BIM activity be curbed in erythroid cells. This notion fits
well with the important finding that production of LRF itself is
activated by GATA1, a master gene of erythropoiesis (Figure 6E).
Finally, our findings also have important implications for the role
of LRF in tumorigenesis because they identify yet another critical
mechanism (the ability to repress BIM with the consequent
survival advantage) whereby LRF can lend to the oncogenic
potential of tumor cells.
EXPERIMENTAL PROCEDURES
Mice
Generation of conventional (Zbtb7a+/) and conditional (Zbtb7aFlox/+) Lrf
knockout mice was described elsewhere (Maeda et al., 2007). Mx1-Cre trans-
genic mice (Gu et al., 1994), Bim (Bcl2l11) knockout mice (Bouillet et al., 1999),
and the congenic strain that carries the CD45.1 antigen (B6.SJL-PtprcaPepcb/
BoyJ) were purchased from Jackson Laboratory.
Analysis of Embryonic PB and Colony Forming Assay
PB was collected with a micropipette from the carotid arteries of embryos and
smears were prepared for Wright-Giemsa staining. Hematocrit was deter-
mined using microhematocrit tubes (Microcaps, Drummond Scientific). FL
colony-forming assays in methylcellulose were performed as previously
described (Wang et al., 1998). For the CFU-E colony assay in Lrf conditional
knockout mice, 10,000 flow-sorted the MEPs were cultured in EPO-containing
methylcellulose plates (MethoCult M3334, StemCell Technologies) for 2 days
and colony numbers were subsequently counted.
FACS and Cell Purification
After blocking nonspecific antibody binding by incubating with FcBlock (BD),
FL and BM cells were incubated with fluorochrome-conjugated (or with
biotin-conjugated) antibodies. FACS analysis was performed in FACScan,
FACSCalibur, or CyAn (DAKO), followed by analysis with FlowJo software
(Tree Star). Cell sorting was performed on a MoFlo at MSKCC and BIDMC
Flow Cytometry Core Facility using DAPI for live/dead discrimination. Anti-
bodies for FACS and cell sorting were purchased from eBioscience unless
otherwise indicated. FACS analysis for Phospho-Stat5 was performed accord-
ing to the phospho-FACS protocol from the lab of Dr. Kevin Shannon (http://
www.ucsf.edu/kmslab/resources/resources.html) using AlexaFluor647-con-
jugated anti-PhosphoStat5 antibody (pY694, clone47, BD). For cell cycle anal-
ysis, DRAQ5 (Axxora) was added to a final concentration of 10 mM and cells
were subsequently incubated for 10 min at room temperature. For Annexin V
staining, FL cells were suspended with 1 x Annexin Biding Buffer (BD) contain-
ing 2% fetal bovine serum, stained with FITC-anti-CD71, PE-anti-Ter119 anti-
bodies, and APC-Annexin V (BD) following the manufacturer’s protocol.
Conditional Inactivation of Lrf and PB Analysis in Adult Mice
Cre recombinase was induced at the HSC level as previously described
(Gu et al., 1994). PB samples were collected from the retro-orbital sinus with
heparinized capillary tubes (Fisher Scientific) under isoflurane anesthesia.538 Developmental Cell 17, 527–540, October 20, 2009 ª2009 ElseRBC counts, hematocrit, hemoglobin, and MCV were measured using an Adivia
120 hematology analyzer (Bayer). Serum erythropoietin level was measured
using the Mouse/Rat Erythropoietin Quantikine ELISA Kit (R&D Systems).
PHZ Treatment and Collection of Splenic Erythroblasts
Phenylhydrazine (PHZ) was purchased from Sigma and injected subcutane-
ously three times at the dose of 40 mg/kg as previously described (Socolovsky
et al., 2001). For CD71+ splenic erythroblast collection, the spleen was
isolated at day 4 after PHZ stimulation and cells were then incubated with
anti-CD71 biotin conjugated antibody (C2, BD), followed by incubation with
anti-Biotin MicroBeads (Miltenyi Biotec). The cell suspension was subse-
quently applied onto MACS separation LS columns (Miltenyi Biotec) for posi-
tive selection.
Microarray Analysis
One Zbtb7a+/+, one Zbtb7a+/, and two Zbtb7a/ 12.5 d.p.c. FLs were
isolated from littermate embryos. RNA of CD71+Ter119 erythroblasts was
extracted according to the manufacturer’s specifications. cDNA synthesis,
cRNA labeling, and hybridization onto GeneChip Mouse Genome 430A2.0
chips (Affymetrix) was performed as previously described (Costoya et al.,
2004). Because Zbtb7a+/ mice do not demonstrate any gross defect, we
divided samples into two groups. Data sets from one Zbtb7a+/+ and one
Zbtb7a+/ samples were defined as a control group and the data sets from
two Zbtb7a/ samples were defined as a knockout group. Raw expression
data on each chip was generated utilizing the Affymetrix Microarray Suite
5.0. Genes whose normalized data value were greater or less by more than
1.5-fold between two groups were selected and further evaluated statistically
(Parametric test using Welch’s approximate t test, with p value cutoff of 0.05)
using GeneSpring software (SiliconGenetics).
In Vitro Hematopoietic Differentiation of Mouse Embryonic
Stem Cells
Wild-type and Gata1 null ES cells (Weiss et al., 1994; Pevny et al., 1991) were
retrovirally infected with mock or Lrf-expressing vector followed by selection
with puromycin on gelatinized dish. In vitro differentiation of ESCs, cell sorting,
and colony-forming assays were performed as reported previously (Umeda
et al., 2004, 2006). Floating hematopoietic cells that emerged after cell sorting
were processed every 3 days for May-Giemsa staining as described previously
(Umeda et al., 2004, 2006).
Identification of Potential cis-Regulatory Elements
To identify regions to be analyzed by ChIP, we examined the Lrf genomic locus
in the UCSC Genome Browser along with a custom track showing erythroid
predicted cis-regulatory modules (preCRMs) (Wang et al., 2006). Erythroid
preCRMs are regions of high regulatory potential (Elnitski et al., 2003) contain-
ing at least one conserved consensus GATA1 binding motif (WGATAR). A
435 bp preCRM was identified immediately upstream of the start of transcrip-
tion. Examination of the preCRM in the murine Lrf promoter revealed 2
consensus GATA1 binding motifs (WGATAR) and 3 consensus EKLF binding
motifs (CCNCNCCCN).
Lrf Promoter Reporter Assay
Two milligrams of Lrf-PGL-4 reporter plasmid and 0.2 mg Renilla luciferase
reporter plasmid (pRL) were transfected into MEL cells using Lipofectamine
LTX+ Plus reagents (Invitrogen). Where indicated, MEL cells were induced
toward erythroid maturation by addition of 5 mM hexamethylene bisacetamide
for 72 hr prior to transfection. Luciferase activity was measured 24 hr after
transfection using the Dual-Luciferase Reporter Assay system (Promega).
Reported luciferase activities are normalized for transfection efficiency
according to Renilla activities.
Bim Promoter Reporter Assay
pGL3-mBim0.8 reporter plasmid, containing 800 bp region immediately
upstream of exon 1 of mouse Bim gene, was generated from the p0.8 vector
(kind gift from Dr. Jerry M. Adams) (Bouillet et al., 2001). Truncated mutants
(pDSacII, p0.25, p0.1 and p0.25S) were generated by enzyme digestion. Muta-
genesis was then performed using a Change-IT mutagenesis kit (USB Corpo-
ration, Cleveland, OH).vier Inc.
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